- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials Sponsored by Biogen Idec
Total 2142 results
-
AbbottBiogenTerminated
-
Reata, a wholly owned subsidiary of BiogenTerminatedChronic Kidney Diseases | Autosomal Dominant Polycystic Kidney | Alport SyndromeUnited States, France, Australia, Japan, Spain, Puerto Rico
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetic NephropathyUnited States
-
Reata, a wholly owned subsidiary of BiogenWithdrawn
-
Reata, a wholly owned subsidiary of BiogenCompletedMelanoma | Unresectable (Stage III) Melanoma | Metastatic (Stage IV) MelanomaUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedHealthy VolunteersUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetes Mellitus, Type 2 | Renal Insufficiency, ChronicUnited States
-
Wageningen UniversityStichting IMEC-NLCompletedProtein FermentationNetherlands
-
Laboratoire Innotech InternationalITEC ServicesCompletedContraceptionFrance, Russian Federation
-
PfizerITEC GROUP 3Completed
-
Knopp BiosciencesBiogenCompleted
-
BiogenAlkermes, Inc.CompletedRelapsing Remitting Multiple SclerosisUnited States, Germany, Poland
-
Genentech, Inc.BiogenCompleted
-
BiogenElan PharmaceuticalsCompleted
-
BiogenElan PharmaceuticalsTerminatedRheumatoid ArthritisUnited States, Canada
-
BiogenElan PharmaceuticalsCompletedCrohn's DiseaseUnited States
-
BiogenElan PharmaceuticalsWithdrawn
-
BiogenElan PharmaceuticalsCompletedRelapsing-Remitting Multiple Sclerosis | Secondary Progressive Multiple SclerosisUnited States
-
BiogenElan PharmaceuticalsCompletedMultiple Sclerosis | Pregnancy | Crohn's Disease | Prenatal ExposureUnited States
-
BiogenAcorda TherapeuticsCompleted
-
BiogenCrescendo BiosciencesCompletedArthritis, RheumatoidUnited States
-
BiogenElan PharmaceuticalsCompleted
-
Facet BiotechBiogenTerminatedPeritoneal Neoplasms | Ovarian CancerUnited States, Canada
-
Uni-PharmaBiogenCompletedChronic Plaque Psoriasis
-
Reata, a wholly owned subsidiary of BiogenNot yet recruiting
-
Reata, a wholly owned subsidiary of BiogenTerminatedAutosomal Dominant Polycystic Kidney | ADPKDUnited States, Spain, United Kingdom, Australia, France, Japan, Germany, Belgium, Czechia, Italy
-
Reata, a wholly owned subsidiary of BiogenTerminatedConnective Tissue Disease-Associated Pulmonary Arterial HypertensionUnited States, Spain, Japan, Australia, United Kingdom, Canada, Germany, Belgium, Argentina, Israel, Mexico, Brazil, Czechia, Netherlands, Philippines
-
Reata, a wholly owned subsidiary of BiogenTerminatedPulmonary HypertensionUnited States, Spain, Australia, United Kingdom, Canada, Belgium, Argentina, Israel, Japan, Philippines, Germany, Mexico, Brazil, Czechia, Netherlands
-
Reata, a wholly owned subsidiary of BiogenCompletedFocal Segmental Glomerulosclerosis | IgA Nephropathy | Autosomal Dominant Polycystic Kidney | CKD Associated With Type 1 DiabetesUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedChronic Kidney DiseasesUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedIdiopathic Pulmonary Fibrosis | Pulmonary Arterial Hypertension | Pulmonary Hypertension | Interstitial Lung Disease | Sarcoidosis | Idiopathic Interstitial Pneumonia | Cryptogenic Organizing Pneumonia | Desquamative Interstitial Pneumonia | Respiratory Bronchiolitis Associated Interstitial Lung Disease and other conditionsUnited States, Germany
-
Reata, a wholly owned subsidiary of BiogenTerminatedBrain MetastasesUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenTerminatedDiabetes Mellitus, Type 2 | Renal Insufficiency, Chronic
-
Reata, a wholly owned subsidiary of BiogenCompletedAlport SyndromeUnited States, United Kingdom, Japan, Australia, France, Germany, Puerto Rico, Spain
-
Reata, a wholly owned subsidiary of BiogenTerminatedLeptomeningeal CarcinomatosisUnited States
-
Reata, a wholly owned subsidiary of BiogenCompletedDiabetic Nephropathy | Type 2 Diabetes | Chronic Kidney DiseaseUnited States
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompleted
-
Reata, a wholly owned subsidiary of BiogenCompletedAdvanced Solid Tumors | Lymphoid MalignanciesUnited States
-
Reata, a wholly owned subsidiary of BiogenTerminatedPancreatic Neoplasms | Pancreatic CancerUnited States
-
Reata, a wholly owned subsidiary of BiogenNo longer available
-
Sage TherapeuticsBiogenRecruitingMajor Depressive DisorderUnited States
-
Stanford UniversityBiogenActive, not recruitingMyotonic Dystrophy 1United States
-
BiogenApple Inc.TerminatedMild Cognitive Impairment | Normal AgingUnited States
-
Eisai Inc.BiogenActive, not recruitingAlzheimer's DiseaseUnited States, Canada, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, Sweden, United Kingdom
-
BiogenAlkermes, Inc.CompletedMultiple SclerosisUnited States, Bulgaria, Poland, Belgium, Canada, Germany, Russian Federation, Serbia, Spain, Ukraine
-
Rigshospitalet, DenmarkBiogenCompletedPrimary Progressive Multiple SclerosisDenmark
-
BiogenElan PharmaceuticalsCompletedRelapsing Remitting Multiple Sclerosis (RRMS)Belgium, Mexico, Poland, Romania, Saudi Arabia, Ukraine